|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Medical apparatus for introducing pharmaceutical
preparations into the human body, also for urol... |
|
|
Invention
|
Antibodies to pyroglutamate amyloid-b and uses thereof.
The invention provides antibodies or ant... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of autoimmune diseases and disorder... |
|
|
Invention
|
Inhibitors of malt1 and methods of their use. Methods for treating a B-cell malignancy in a human... |
|
|
Invention
|
Formulations, crystalline forms and dosage regimens of a malt1 inhibitor. The present invention r... |
|
|
Invention
|
Cell manufacturing management platform using machine learning. A cell manufacturing management pl... |
|
|
Invention
|
Methods and systems for microbial detection using raman and infrared spectroscopy. Provided is a ... |
|
|
Invention
|
Compounds and uses thereof.
The present invention features compounds useful in the treatment of ... |
|
|
Invention
|
Imidazopyridazine il-17 inhibitor compounds. The present application discloses compounds having t... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for human use. |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of auto-immune and inflammato... |
|
|
Invention
|
Triazolo[4,5-b]pyridine compounds useful as inhibitors of werner syndrome recq helicase (wrn). Th... |
|
|
Invention
|
Substituted pyrrolidine-2-carboxylic acid derivatives as cgas inhibitors. [0366] Compounds of For... |
|
|
Invention
|
Substituted pyrrolidine-2-carboxylic acid derivatives as cgas inhibitors.
Compounds of Formula (... |
|
|
Invention
|
Lipids for nanoparticle delivery platform. The present disclosure includes ionizable lipids suita... |
|
|
Invention
|
Crystal form of a peptide inhibitor of interleukin-23 receptor. The present disclosure relates to... |
|
|
Invention
|
Formulation/compositions comprising ibrutinib.
Disclosed are formulations/compositions comprisin... |
|
|
Invention
|
Methods for the treatment of depression.
The present invention is directed to methods and dosing... |
|
|
Invention
|
Crystalline forms of 3-(7-chloro-1h-indazol-5-yl)-2,5-bis(trifluoromethyl)-3h-imidazo[4,5-b]pyrid... |
|
|
Invention
|
Pharmaceutical composition of s-ketamine hydrochloride.
The present invention is directed to an ... |
|
|
Invention
|
Methods of treating depression using orexin-2 receptor antagonists.
The present disclosure is di... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor and uses thereof. Uses of a peptide inhibitor of th... |
|
|
Invention
|
Coronavirus inhibiting compounds. The present invention relates to compounds of formula (I) for t... |
|
2024
|
Invention
|
Imidazopyridazine il-17 inhibitor compounds.
The present application discloses compounds having ... |
|
|
Invention
|
Methods for treating subjects with autism spectrum disorder. A method of treating Autism Spectrum... |
|
|
Invention
|
Intrabodies targeting intracellular tau. The present invention provides a method of binding intra... |
|
|
Invention
|
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic gl... |
|
|
Invention
|
Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators.
Substituted Py... |
|
|
Invention
|
(r) -n-ethyl-5-fluoro-n-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhe... |
|
|
Invention
|
Anti-human vista antibodies and use thereof.
The invention provides agonistic anti-human VISTA a... |
|
|
Invention
|
Synthesis of a bruton's tyrosine kinase inhibitor.
Described herein is the synthesis of Bruton's... |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments. |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments; trocar... |
|
2023
|
Invention
|
Collaborative frameworks for improving regulatory decision-making of measurement solutions.
In a... |
|
|
Invention
|
Methods for mitigating lung injury in conjunction with exposure to radiation and/or radiation or ... |
|
|
Invention
|
Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinase.
The present disclosure rel... |
|
|
Invention
|
Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinase.
The present disclosure re... |
|
|
Invention
|
Metabolite predictors for lung cancer.
Disclosed herein are methods for analyzing predictors inc... |
|
|
Invention
|
Crystalline forms of an inhibitor of the menin/mll interaction.
The present invention relates to... |
|
|
Invention
|
Multispecific antibodies and uses thereof.
Provided are multispecific antibodies or antigen bind... |
|
|
Invention
|
Synthesis of bruton's tyrosine kinase inhibitors.
The present disclosure is directed to methods ... |
|
|
Invention
|
Expression systems for the alpha6-containing nicotinic acetylcholine receptor and methods of use ... |
|
|
Invention
|
Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with m... |
|
|
Invention
|
Antagonist of adenosine receptors.
The present invention relates to compounds of formula I shown... |
|
2022
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of viral diseases, auto-immun... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer for
human use. |
|
|
P/S
|
Vaccines. |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of oncological diseases and d... |
|
|
Invention
|
Pyridazines or 1,2,4-triazines substituted by spirocyclic amines.
The present invention relates ... |
|
|
Invention
|
Combination therapies.
Disclosed are combinations comprising a therapeutically effective amount ... |
|
|
Invention
|
Expression systems for the alpha2alpha5beta2 nicotinic acetylcholine receptor and methods of use ... |
|
|
Invention
|
Expression systems for the alpha6beta4 nicotinic acetylcholine receptor and methods of use thereo... |
|
|
Invention
|
Methods for identifying binding partners of progranulin.
Disclosed herein are screening methods ... |
|
|
Invention
|
Pyrazolopyrimidines as modulators of spermine oxidase.
The present invention comprises compounds... |
|
2020
|
Invention
|
Intranasal drug delivery device |
